Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of KW-0761 in CCR4-positive peripheral T/NK-cell lymphoma
jRCT2080221219Phase 2
- Sponsor
- Kyowa Kirin
- Start
- Aug 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mogamulizumab in peripheral T-cell lymphoma (PTCL) and natural killer/T-cell lymphoma (NKTL), sponsored by Kyowa Kirin.
02
Drugs
mogamulizumab
03
Conditions
peripheral T-cell lymphoma (PTCL)natural killer/T-cell lymphoma (NKTL)
Beyond the preview
Go deeper on jRCT2080221219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221219.